Certified by Founder Lodge
Nilo Therapeutics
United States - New York City
START UP
1 Disclosed Funding Rounds $101,000,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Nilo Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinar
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 10 ,2025 | Series A | $101,000,000 |
The Column Group
DCVC Bio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
AiPrise | $12,500,000 | (Oct 10, 2025)
Arthrosi Therapeutics, Inc. | $153,000,000 | (Oct 10, 2025)
Glue(US) | $20,000,000 | (Oct 10, 2025)
enurgen | $4,100,000 | (Oct 10, 2025)
Affinia Therapeutics | $40,000,000 | (Oct 10, 2025)
